They highlight the unique ability of APP among neurodegenerative disease-relevant substrates to be cleaved by CTSA and CTSH, and underscore the importance of systematically profiling these enzymes to better understand their potential roles in Alzheimer’s disease. This evidence concerns the gene APP and neurodegenerative disease.